JACS 10-K & 10-Q changes, risk factors and insider trading
Jackson Acquisition Co II (also JACS-RI, JACS-UN) · NYSE · Blank Checks · CIK 2039058 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
As a smaller reporting company, we are not required to include risk factors in this Annual Report.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
“In connection with the Company’s assessment of going concern considerations in accordance with ASC 205-40, “Presentation of Financial Statements – Going Concern,” as of December 31, 2025, the Company has determined that mandatory liquidation and subsequent dissolution, should the Company be unable to complete a Business Combination, raises substantial doubt about the Company’s ability to continue as a going concern. The Company has until December 11, 2026 to consummate a Business Combination. …”see in full comparison
“In connection with our assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management believes that the funds which the Company has available following the completion of the initial public offering will enable it to sustain operations for a period of at least one year from the issuance date of these financial statements.”see in full comparison
“In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. …”see in full comparison
“In November 2024, the FASB issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. …”see in full comparison
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an aggregate of $10,000 per month for office space and administrative and support services.see in full comparisonAsForofthe year ended December 31, 2025 and for the period from September 11, 2024 (inception) through December 31, 2024,the Companywe incurred$7,000$120,000ofandadministrative$7,000, respectively, for these services. At Decemberservices31,fees2025whichandwas2024,includedweinowedaccrued$127,000expensesandin$7,000,therespectively,accompanyingforbalancethesesheet.services.
“For the year ended December 31, 2025, net cash used in operating activities was $427,590. Net income of $9,115,597 was offset by interest earned on marketable securities of $9,684,710 and changes in operating assets and liabilities, which provided $141,523 of cash from operating activities.”see in full comparison
Full comparison: every changed paragraph (17)
References to the “Company,”
“us,” “our,” or “we” refer to Jackson Acquisition Company II. The following discussion and analysis
of our financial condition and results of operations should be read in conjunction with our audited financial statements and related notes
herein.
References to the “Company,”
“us,” “our,” or “we” refer to Jackson Acquisition Company II. The following discussion
and analysis
of the Company’s financial condition and results of operations should be read in conjunction with our audited financial statements
statements and the notes related thereto which are included in “Item 8. Financial Statements and Supplementary Data” of this Annual
Annual Report on Form 10-K. Certain information contained in the discussion and analysis set forth below includes forward-looking statements.
Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including
those set forth under “Special Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors” and elsewhere
in this Annual Report on Form 10-K.
We are a blank check company
incorporated in the Cayman Islands on September 11, 2024 formed for the purpose of effecting a merger, amalgamation, share exchange,
asset acquisition,
share purchase, reorganization or other similar business combination with one or more businesses (“Business
Combination”). We intend
to effectuate our Business Combination using cash derived from the proceeds of the IPOInitial Public Offering
and the sale of the Private Placement Units, our
shares, debt or a combination of cash, shares and debt.
We have neither engaged in
any operations nor
generated any revenues to date. Our only activities from September 11, 2024 (inception) through December 31, 2024
2025 were organizational
activities, those necessary to prepare for the IPO,Initial Public Offering, described below, and identifying a target
company for a Business Combination. We do
not expect to generate any operating revenues until after the completion of our Business Combination.
We generate non-operating income
in the form of interest income on marketable securities held in the Trust Account. We incur expenses
as a result of being a public company
(for legal, financial reporting, accounting and auditing compliance), as well as for due diligence
expenses.
For the year ended December 31, 2025, we had net income of $9,115,597, which consists of interest earned of marketable securities held in the Trust Account of $9,684,710, offset by general and administrative expenses of $569,113.
On December 11, 2024, we
consummated the Initial Public Offering of
23,000,000 Units, which includes the full exercise by the underwriters of their over-allotment
option in the amount of 3,000,000 Units,
at $10.00 per Unit, generating gross proceeds of $230,000,000. Simultaneously with the closing
of the Initial Public Offering, we consummated
the sale of 840,000 Private Placement UnitUnits at a price of $10.00 per Private Placement
Unit in a private placement to the Sponsor and Roth
Capital Partners, LLC, representative of the underwriters (“Roth”), generating
gross proceeds of $8,400,000.
Following the Initial Public
Offering, the full exercise of the over-allotment option, and the sale of the Private Placement Unit,Units, a total of $232,300,000 was placed
in the Trust Account. We incurred transaction costs of $5,157,741, consisting of $4,600,000 of cash underwriting fee and $557,741 of
other other
offering costs.
For the year ended December 31, 2025, net cash used in operating activities was $427,590. Net income of $9,115,597 was offset by interest earned on marketable securities of $9,684,710 and changes in operating assets and liabilities, which provided $141,523 of cash from operating activities.
At December 31, 2024, 2025,
we had investmentsmarketable securities held
in the Trust Account of $232,858,478.$242,543,188. We intend to use substantially all of the funds held in the Trust
Account, including any amounts
representing interest earned onin the Trust Account, which interest shall be net of taxes payable, if any,
to complete ouran initial Business Combination.
We may withdraw interest from the Trust Account to pay taxes, if any. To the extent that
our share capital or debt is used, in whole or
in part, as consideration to complete a Business Combination, the remaining proceeds held
in the Trust Account will be used as working
capital to finance the operations of the target business or businesses, make other acquisitions
and pursue our growth strategies.
In order to fund working
capital deficiencies
or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor
or certain of our officers
and directors may, but are not obligated to, loan us funds as may be required (“Working Capital Loans”).
If we complete a
Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the
event that a Business
Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay
such loaned amounts, but
no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such Working Capital
Loans for each such person
may be convertible into Units of the post-Business Combination entity at a price of $10.00 per Unit. At December
31, 31,2025 and 2024, no amounts
were outstanding under the Working Capital Loans.
We do not believe we willmay need to raise additional
funds in order to meet the expenditures
required for operating our business. However, if our estimate of the costs of identifying a target
business, undertaking in-depth due
diligence and negotiating a Business Combination are less than the actual amount necessary to do so,
we may have insufficient funds available
to operate our business prior to our initial Business Combination. Moreover, we may need to obtain
additional financing either to complete
our Business Combination or because we become obligated to redeem a significant number of our
public shares upon completion of our Business
Combination, in which case we may issue additional securities or incur debt in connection
with such Business Combination.
In connection with the Company’s assessment of going concern considerations in accordance with ASC 205-40, “Presentation of Financial Statements – Going Concern,” as of December 31, 2025, the Company has determined that mandatory liquidation and subsequent dissolution, should the Company be unable to complete a Business Combination, raises substantial doubt about the Company’s ability to continue as a going concern. The Company has until December 11, 2026 to consummate a Business Combination. Additionally, the expectation of significant future costs raises substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. Management plans to address this uncertainty through debt or equity financing. There is no assurance that our plans to raise capital or to consummate a business combination will be successful within the Completion Window. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution.
In connection with our assessment
of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties
about an Entity’s Ability to Continue as a Going Concern,” management believes that the funds which the Company has available
following the completion of the initial public offering will enable it to sustain operations for a period of at least one year from the
issuance date of these financial statements.
We do not have any long-term
debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an aggregate of
$10,000 per month for office space and administrative and support services. AsFor ofthe year ended December 31, 2025 and for the period from
September 11, 2024 (inception) through December 31, 2024, the Companywe incurred $7,000$120,000 ofand administrative$7,000, respectively, for these services. At December
services31, fees2025 whichand was2024, includedwe inowed accrued$127,000 expensesand in$7,000, therespectively, accompanyingfor balancethese sheet.services.
TheWe Company hashave engaged Roth as an
advisor in
connection with its Business Combination. The CompanyWe will pay Roth a cash fee (the “Business Combination Marketing Fee”)
for such services upon the consummation of its initial
Business Combination in an amount up to 4.0% of the gross proceeds of the Initial
Public Offering, an aggregate of up to $9,200,000 after
the underwriters exercised their over-allotment option in full on December 11,
2024. As of December 31, 2025 and 2024, no Business Combination
Marketing Fee has been incurred or recorded.
In November 2024, the FASB issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.
In August 2020, the FASB issued
Accounting Standards Update (“ASU”) No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s
Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required
under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the
derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The provisions of ASU 2020-06
are applicable for fiscal years beginning after December 15, 2023, with early adoption permitted no earlier than fiscal years beginning
after December 15, 2020. The Company adopted ASU 2020-06 during the period of the audit on a prospective basis. The adoption of ASU 2020-06
has not had a material impact on the Company’s consolidated financial statements and disclosures.
What changed in the latest 10-Q
Risk Factors
Largest changes
“The NYSE’s acceptance of our plan is subject to ongoing conditions, and our continued listing during the Plan Period is not assured. Our plan is heavily dependent on the announcement or completion of a contemplated Business Combination, and our failure to demonstrate consistent progress toward that goal could result in the NYSE subjecting us to immediate reassessment. To regain compliance, we must achieve the minimum continued listing standard of at least 300 total stockholders by the completion of the cure period. …”see in full comparison
On February 6, 2026, we received a notice from the NYSE that we were not in compliance with NYSE listing standard 802.01B because we had fallen below compliance with the 300 public shareholders requirement. In accordance with the NYSE listing requirements, we submitted a plan on March 19, 2026 that demonstrated how we expected to return to compliance with NYSE listing standard 802.01B.see in full comparisonTheOnnoticeAprilhas29,no immediate impact on the listing or trading of our securities on the NYSE. If2026, the NYSEapproves ournotifiedplan,us it had accepted oursecuritiesplan and that we areexpectedeligible to continuetoourbelistinglistedduringandatradedplan period that expires on August 6, 2027 (theNYSE“Planduring the applicable cure period,Period”), subject to our compliance with other NYSE continued listing standards and periodic review by the NYSE of our progress under the plan.
Full comparison: every changed paragraph (2)
On February 6, 2026, we received a notice from the NYSE that we were
not in compliance with NYSE listing standard 802.01B because we had fallen below compliance with the 300 public shareholders requirement.
In accordance with the NYSE listing requirements, we submitted a plan on March 19, 2026 that demonstrated how we expected to return to compliance with NYSE
listing standard 802.01B. TheOn noticeApril has29, no immediate impact on the listing or trading of our securities on the NYSE. If2026, the NYSE approves
ournotified plan,us it had accepted our securitiesplan and that we are expectedeligible to continue toour belisting listedduring anda tradedplan period that expires on August 6, 2027 (the NYSE“Plan during the applicable cure period,Period”), subject to our
compliance with other NYSE continued listing standards and periodic review by the NYSE of our progress under the plan.
The NYSE’s acceptance of our plan is subject to ongoing conditions, and our continued listing during the Plan Period is not assured. Our plan is heavily dependent on the announcement or completion of a contemplated Business Combination, and our failure to demonstrate consistent progress toward that goal could result in the NYSE subjecting us to immediate reassessment. To regain compliance, we must achieve the minimum continued listing standard of at least 300 total stockholders by the completion of the cure period. The NYSE will commence suspension and delisting procedures against us if we fail to satisfy the applicable requirements at the appropriate time, and we can provide no assurance that we will regain compliance with NYSE listing standard 802.01B within the Plan Period or maintain compliance with the NYSE’s other continued listing standards.
Management's Discussion & Analysis (MD&A)
Largest changes
“For the three months ended March 31, 2026, net cash used in operating activities was $128,309. Net income of $1,969,083 was offset by interest earned on marketable securities of $2,137,355 and changes in operating assets and liabilities, which provided $39,963 of cash from operating activities.”see in full comparison
“For the six months ended June 30, 2025, net cash used in operating activities was $227,705. Net income of $4,545,737 was offset by interest earned on marketable securities of $4,881,095 and changes in operating assets and liabilities, which provided $107,653 of cash from operating activities.”see in full comparison
“For the six months ended June 30, 2026, we had net income of $3,949,131, which consists of interest earned on marketable securities held in the Trust Account of $4,301,982 offset by general and administrative expenses of $352,851.”see in full comparison
“For the six months ended June 30, 2025, we had net income of $4,545,737, which consisted of interest earned on marketable securities held in Trust Account of $4,881,095, offset by general and administrative expenses of $335,358.”see in full comparison
For thesee in full comparisonthreesix months endedMarch31,June2025,30, 2026, net cash used in operating activities was$193,398.$163,438. Net income of$2,227,401$3,949,131 was offset by interest earned on marketable securities of$2,433,722$4,301,982 and changes in operating assets and liabilities, which provided$12,923$189,413 of cash from operating activities.
For the three months endedsee in full comparisonMarch31,June 30, 2025, we had net income of$2,227,401,$2,318,336, which consisted of interest earned on marketable securities held in Trust Account of$2,433,722,$2,447,373, offset byoperationalgeneralcostsand administrative expenses of$206,321.$129,037.
Full comparison: every changed paragraph (16)
We have neither engaged in
any operations nor generated any revenues to date. Our only activities from September 11, 2024 (inception) through MarchJune 31,30, 2026 were
organizational activities, those necessary to prepare for the Initial Public Offering, discussed below, and identifying a target company
for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination.
We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses
as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence
expenses.
For the three months ended
March 31,June 30, 2026, we had net income of $1,969,083,$1,980,048, which consists of interest earned on marketable securities held in the Trust Account
of $2,137,355$2,164,627 offset by general and administrative expenses of $168,272.$184,579.
For the three months ended
March 31,June 30, 2025, we had net income of $2,227,401,$2,318,336, which consisted of interest earned on marketable securities held in Trust Account of
$2,433,722, $2,447,373, offset by operationalgeneral costsand administrative expenses of $206,321.$129,037.
For the six months ended June 30, 2026, we had net income of $3,949,131, which consists of interest earned on marketable securities held in the Trust Account of $4,301,982 offset by general and administrative expenses of $352,851.
For the six months ended June 30, 2025, we had net income of $4,545,737, which consisted of interest earned on marketable securities held in Trust Account of $4,881,095, offset by general and administrative expenses of $335,358.
For the three months ended
March 31, 2026, net cash used in operating activities was $128,309. Net income of $1,969,083 was offset by interest earned on marketable
securities of $2,137,355 and changes in operating assets and liabilities, which provided $39,963 of cash from operating activities.
For the threesix months ended
March 31,June 2025,30, 2026, net cash used in operating activities was $193,398.$163,438. Net income of $2,227,401$3,949,131 was offset by interest earned on marketable
securities of $2,433,722$4,301,982 and changes in operating assets and liabilities, which provided $12,923$189,413 of cash from operating activities.
For the six months ended June 30, 2025, net cash used in operating activities was $227,705. Net income of $4,545,737 was offset by interest earned on marketable securities of $4,881,095 and changes in operating assets and liabilities, which provided $107,653 of cash from operating activities.
At MarchJune 31,30, 2026, we had
marketable securities held in the Trust Account of $244,680,543.$246,845,170. We intend to use substantially all of the funds held in the Trust Account,
including any amounts representing interest earned in the Trust Account, which interest shall be net of taxes payable, if any, to complete
an initial Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any. To the extent that our share capital
or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account
will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our
growth strategies.
At MarchJune 31,30, 2026, we had
cash of $393,467$358,338 held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and
evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or
similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements
of prospective target businesses, structure, negotiate and complete a Business Combination.
In order to fund working
capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor
or certain of our officers and directors may, but are not obligated to, loan us funds as may be required (“Working Capital Loans”).
If we complete a Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the
event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay
such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such Working Capital
Loans for each such person may be convertible into Units of the post-Business Combination entity at a price of $10.00 per Unit. At March
31,June 30, 2026 and December 31, 2025, no amounts were outstanding under the Working Capital Loans.
In connection with the Company’s
assessment of going concern considerations in accordance with ASC 205-40, “Presentation of Financial Statements – Going Concern,”
as of MarchJune 31,30, 2026, the Company has determined that mandatory liquidation and subsequent dissolution, should the Company be unable to
complete a Business Combination, raises substantial doubt about the Company’s ability to continue as a going concern. The Company
has until December 11, 2026 to consummate a Business Combination. Additionally, the expectation of significant future costs raises substantial
doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. Management
plans to address this uncertainty through debt or equity financing. There is no assurance that our plans to raise capital or to consummate
a business combination will be successful within the Completion Window. If a Business Combination is not consummated by this date, there
will be a mandatory liquidation and subsequent dissolution.
We have no obligations, assets
or liabilities, which would be considered off-balance sheet arrangements as of MarchJune 31,30, 2026. We do not participate in transactions that
create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would
have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing
arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial
assets.
We do not have any long-term
debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an aggregate of
$10,000 per month for office space and administrative and support services. For the three and six months ended MarchJune 31,30, 2026 and 20252025, we incurred
$30,000 and $60,000, respectively, for these services. At MarchJune 31,30, 2026 and December 31, 2025, we owed $157,000$187,000 and $127,000, respectively, for these services.
We have engaged Roth as an
advisor in connection with itsour Business Combination. We will pay Roth a cash fee (the “Business Combination Marketing Fee”)
for such services upon the consummation of its initial Business Combination in an amount up to 4.0% of the gross proceeds of the Initial
Public Offering, an aggregate of up to $9,200,000 after the underwriters exercised their over-allotment option in full on December 11,
2024. As of MarchJune 31,30, 2026 and December 31, 2025, no Business Combination Marketing Fee has been incurred or recorded.
The preparation of unaudited
condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States
of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure
of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual
results could materially differ from those estimates. At MarchJune 31,30, 2026, we have not identified any critical accounting estimates.
JACS insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding JACS (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| D. E. Shaw & Co. | 2026-06-30 | 1,138,500 | $12.1M | 0.01% | No change |
| Two Sigma Investments | 2026-06-30 | 474,821 | $5.1M | 0.0% | No change |
| D. E. Shaw & Co. | 2026-06-30 | 250,000 | $35.0K | 0.0% | No change |